Product Review,Molecular Formula, C18H17F3N2O2

The pursuit of effective treatments for neurodegenerative diseases and age-related cognitive decline has led to the investigation of numerous compounds. Among these, peptide J147 has emerged as a significant area of research, demonstrating remarkable potential as a neuroprotective and neurotrophic compound. This experimental drug, derived from curcumin, the active ingredient in turmeric, exhibits a unique profile that suggests it could be a valuable therapeutic agent for conditions such as Alzheimer's disease and other ageing-associated diseases.

J147's Mechanism of Action and Neuroprotective Properties

At its core, J147 is a phenyl hydrazide that exhibits potent neuroprotective and cognition enhancing activities. Its efficacy stems from its ability to act broadly across multiple cellular pathways. Research indicates that J147 works by manipulating ATP, a crucial protein found in mitochondria, which serves as the body's primary energy source. By influencing mitochondrial function, J147 can enhance cellular energy production and promote overall cellular longevity pathways.

Furthermore, J147 has been shown to be a broad spectrum neuroprotective compound in various assays. It protects against neuronal oxidative stress, a key factor in the progression of many neurodegenerative disorders. Its potent neurotrophic properties are also noteworthy, as they are linked to the induction of brain-derived neurotrophic factor (BDNF) levels. BDNF is vital for neuronal survival, growth, and synaptic plasticity, which is the brain's ability to adapt and form new connections. Studies have shown that J147 promotes synaptic plasticity by regulating the expression of Synaptophysin, a protein recognized as a biomarker for synapse loss.

The compound's ability to readily cross the blood-brain barrier is a significant advantage, allowing it to exert its effects directly within the central nervous system. This characteristic is particularly important when considering its origin from curcumin, which, unlike J147, struggles to achieve sufficient brain concentrations. The molecular formula of J147 is C18H17F3N2O2, with a molecular weight of 350.33 and identified by CAS Number 1146963-51-0.

Therapeutic Potential in Alzheimer's Disease and Beyond

The most extensively studied application for J147 is in the treatment of Alzheimer's disease (AD). Its ability to reverse cognitive decline in mouse models of Alzheimer's disease and accelerated aging has generated considerable excitement. Researchers believe J147 has the potential to move forward as a treatment for this debilitating condition, offering not just symptomatic relief but also the possibility of halting or even reversing disease progression.

Beyond Alzheimer's, the therapeutic potential of small peptides like J147 extends to other neurological dysfunctions. J147 is a novel drug candidate developed to treat neurological dysfunction and has demonstrated beneficial effects in various models. For instance, in a diabetic-induced neuropathy model, treatment of J147 over 20 weeks slightly decreased blood glucose and HbA1c levels, suggesting potential benefits for diabetic neuropathy as well. Its broad neuroprotective capabilities also position it as a candidate for addressing other ageing-associated diseases.

J147 has been described as a potential AD therapeutic due to its ability to provide immediate cognition benefits. It is also noted for its capacity to decrease neurotoxicity in cortical neurons in vitro, with an EC50 ranging from 25 to 200 nM. Another key characteristic is its role as a MAO inhibitor, further contributing to its neurochemical effects.

Research and Future Directions

The ongoing research into J147 has provided substantial evidence of its promise. Studies have explored its effects on mitochondrial function, synaptic signaling, and its capacity to reduce tPA-induced brain hemorrhage in acute ischemic stroke models. The compound has been found to decrease neuronal loss in vitro and has shown positive effects in reversing aspects of aging in mice.

While J147 is an experimental drug, its attributes — including its potent neuroprotective nature, cognition enhancing capabilities, and its ability to provide systemic cellular support through mitochondrial efficiency and oxidative stress reduction — make it a compelling subject for further clinical investigation. The development of J147 represents a significant step forward in the quest for effective interventions against neurodegenerative diseases and the broader challenges of cognitive aging.